EP3054927
Efnablöndur (S)-3-(4-((4-(Morfólínómetýl)Bensóloxý)-1-Ísóindólín-2-ýl)Píperidín-2,6-Díon
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
7.10.2014EP published:
20.2.2019EP application number:
14786429.2
EP translation filed:
26.4.2019Grant published:
15.5.2019EPO information:
European Patent Register
Max expiry date:
6.10.2034Expiry date:
6.10.2026Next due date:
31.10.2026
Title:
FORMULATIONS OF (S)-3-(4-((4-(MORPHOLINOMETHYL)BENZYLOXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE
Timeline
Today
7.10.2014EP application
20.2.2019EP Publication
26.4.2019Translation submitted
15.5.2019Registration published
6.10.2026Expires
Owner
Name:
Celgene CorporationAddress:
86 Morris Avenue, 07901, Summit, NJ, US
Inventor
Name:
PARIKH, DarshanAddress:
Bridgewater, NJ, US
Name:
MENON, AnilAddress:
Martinsville, NJ, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201361888419 PDate:
8.10.2013Country:
US
Classification
Categories:
A61K 9/48
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 18.9.2019
Expires: 6.10.2020
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 9.9.2020
Expires: 6.10.2021
Payer: Árnason Faktor ehf.
Number: 8
Paid: 7.9.2021
Expires: 6.10.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 7.9.2022
Expires: 6.10.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 25.9.2023
Expires: 6.10.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 17.9.2024
Expires: 6.10.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 2.10.2025
Expires: 6.10.2026
Payer: Árnason Faktor ehf.